News
CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...
A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...
Abiotic stresses, including salinity, drought, heat, cold, and heavy metal toxicity, represent a significant challenge to the ...
The Wistar Institute has appointed Qingsheng Li, Ph.D., to its HIV Cure and Viral Diseases Center in Philadelphia. Originally ...
CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...
1d
Amazon S3 on MSNCRISPR Breakthrough Lets Scientists Reverse BlindnessThe curious minds at ColdFusion explore how a CRISPR breakthrough is allowing scientists to reverse certain types of blindness.
Lord of the Rings' director Peter Jackson and his partner Fran Walsh invested $15 million in Colossal Biosciences to bring ...
Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.
Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...
It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
3d
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItCRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results